It would potentially have major clinical implications, if diseases with elevated suPAR could be treated via reduction of suPAR levels, and would suggest that suPAR was not just a passive by-product of uPAR signaling but could have an active role, at least in kidney disease. The gene discussed is PLAUR; the disease is kidney disorder.